Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation

AIMS: Ivabradine is indicated for heart failure (HF) patients with reduced ejection fraction (HFrEF), but limited data are available with regards to the use of ivabradine in those with a history of paroxysmal atrial fibrillation (AF). To assess the effect of ivabradine in HFrEF patients with paroxys...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu‐Sheng, Jan, Jeng‐Yu, Chang, Jung‐Jung, Lin, Ming‐Shyan, Yang, Teng‐Yao, Wang, Po‐Chang, Chen, Mien‐Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288788/
https://www.ncbi.nlm.nih.gov/pubmed/35560828
http://dx.doi.org/10.1002/ehf2.13966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288788/
https://www.ncbi.nlm.nih.gov/pubmed/35560828
http://dx.doi.org/10.1002/ehf2.13966

Ejemplares similares